Outcome Comparison Between Insulin-Dependent and Non Insulin-Dependent Patients after Open Adult Cardiac Surgery

Juni Kurniawaty, Budi Yuli Setianto, Supomo Supomo, Yunita Widyastuti, Cornelia Ancilla, Cindy Elfira Boom


Background: Insulin-dependent diabetic patients usually have poor glycemic control and higher risk of complications than non-insulin-dependent diabetic patients. However, the difference in clinical outcomes between these two groups of patients who underwent open cardiac surgery was not established. Therefore, this study compares the short-term outcome of insulin vs non-insulin-dependent diabetic patients after open cardiac surgery in a large-scale study.

Methods: The study design was a retrospective cohort. All adults who underwent open cardiac surgery between January 1st 2016-December 31st 2020 in 4 tertiary hospitals in Indonesia were included in the study. From a total of 4.931 samples included in the study, 3.753 patients were non-diabetic (Group I) and 1.178 were diabetic (Group II). Group II was divided into subgroup IIA (930 non-insulin-dependent) and subgroup IIB (248 insulin-dependent). The main outcome was in-hospital mortality of open cardiac surgery patients.

Result: In-hospital mortality between group I and II had no significant difference (6.8% vs 5.7%; p = 0.188), as well as IIA and IIB (5.6% vs 6%; p = 0.782). Multivariate analysis demonstrated that diabetes did not increase mortality of open cardiac surgery (OR 0.665; p = 0.021). In-hospital mortality of subgroup IIB was higher than subgroup IIA, but insulin therapy did not increase the risk of in-hospital mortality (OR 1.259; p = 0.464).

Conclusion: Both insulin-dependent and non-insulin-dependent diabetes mellitus were not the predictors of poor short-term outcomes for open adult cardiac surgery patients.


diabetes mellitus; insulin; outcome; open cardiac surgery.

Full Text:



1. Mohr FW, Morice MC, Kappetein AP, Feldman TE, Ståhle E, Colombo A, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. The Lancet. 2013 Feb;381(9867):629–38.

2. Farkouh ME, Domanski M, Dangas GD, Godoy LC, Mack MJ, Siami FS, et al. Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study. J Am Coll Cardiol. 2019 Feb 19;73(6):629–38.

3. Grant SW, Kendall S, Goodwin AT, Cooper G, Trivedi U, Page R, et al. Trends and outcomes for cardiac surgery in the United Kingdom from 2002 to 2016. JTCVS Open. 2021 Sep;7:259–69.

4. Bos M, Agyemang C. Prevalence and complications of diabetes mellitus in Northern Africa, a systematic review. BMC Public Health. 2013 Apr 25;13:387.

5. Glovaci D, Fan W, Wong ND. Epidemiology of Diabetes Mellitus and Cardiovascular Disease. Curr Cardiol Rep. 2019 Apr 4;21(4):21.

6. Natarajan K, Narayanan A, Hemapriya R, Swetha S, Jayashree R, Ninan B. Impact of elevated glycosylated hemoglobin (HbA1c) on the outcome following coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2019 Sep;33:S158.

7. Chadli A, El Aziz S, El Ansari N, Ajdi F, Seqat M, Latrech H, et al. Management of diabetes in Morocco: results of the International Diabetes Management Practices Study (IDMPS) - wave 5. Ther Adv Endocrinol Metab. 2016 Jun;7(3):101–9.

8. Blumenfeld O, Na’amnih W, Shapira-Daniels A, Lotan C, Shohat T, Shapira OM. Trends in Coronary Revascularization and Ischemic Heart Disease-Related Mortality in Israel. J Am Heart Assoc. 2017 Feb 17;6(2).

9. Toh K, Dill-Russell P, Valencia O. Diabetes mellitus and morbidity and mortality risks after cardiac surgery. Crit Care. 2001 Dec 4;5(S6):4.

10. Zalewska-Adamiec M, Bachorzewska-Gajewska H, Malyszko J, Tomaszuk-Kazberuk A, Nowak K, Hirnle T, et al. Impact of diabetes on mortality and complications after coronary artery by-pass graft operation in patients with left main coronary artery disease. Adv Med Sci. 2014 Sep;59(2):250–5.

11. Ram E, Sternik L, Klempfner R, Iakobishvili Z, Fisman EZ, Tenenbaum A, et al. Type 2 diabetes mellitus increases the mortality risk after acute coronary syndrome treated with coronary artery bypass surgery. Cardiovasc Diabetol. 2020 Dec 13;19(1):86.

12. Musa AF, Cheong XP, Yap CG, Dillon J, Nordin R Bin. Does diabetes mellitus increase the mortality risk in coronary artery disease patients undergoing coronary artery bypass grafting surgery at the National Heart Institute of Kuala Lumpur? J Diabetes Metab Disord Control. 2018 Aug 16;5(4):141–3.

13. Li Z, Amsterdam EA, Young JN, Hoegh H, Armstrong EJ. Contemporary Outcomes of Coronary Artery Bypass Grafting Among Patients With Insulin-Treated and Non-Insulin-Treated Diabetes. Ann Thorac Surg. 2015 Dec;100(6):2262–9.

14. Munnee K, Bundhun PK, Quan H, Tang Z. Comparing the Clinical Outcomes Between Insulin-treated and Non-insulin-treated Patients With Type 2 Diabetes Mellitus After Coronary Artery Bypass Surgery. Medicine. 2016 Mar;95(10):e3006.

15. Marfella R, Sardu C, Mansueto G, Napoli C, Paolisso G. Evidence for human diabetic cardiomyopathy. Acta Diabetol. 2021 Aug;58(8):983–8.

16. Ujueta F, Weiss EN, Sedlis SP, Shah B. Glycemic Control in Coronary Revascularization. Curr Treat Options Cardiovasc Med. 2016 Feb;18(2):12.


  • There are currently no refbacks.